Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018–2020)
出版年份 2021 全文链接
标题
Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018–2020)
作者
关键词
-
出版物
INFECTION
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-19
DOI
10.1007/s15010-021-01668-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK
- (2020) Jean L Mbisa et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of Resistance to Integrase Strand Transfer Inhibitors during Dolutegravir Containing Triple-Therapy in a Treatment-Experienced Patient with Pre-Existing M184V/I Mutation
- (2020) Dominique L. Braun et al. Viruses-Basel
- Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
- (2020) Mark J. Siedner et al. Nature Communications
- Mutations altering acetylated residues in the CTD of HIV-1 integrase cause defects in proviral transcription at early times after integration of viral DNA
- (2020) Shelby Winans et al. PLoS Pathogens
- Absence of Integrase Inhibitor-Associated Resistance Among Antiretroviral Therapy-Naïve HIV-1-Infected Adults in Guangdong Province, China, in 2018
- (2020) Yun Lan et al. Infection and Drug Resistance
- Lack of HIV-1 integrase inhibitor resistances among 392 antiretroviral-naïve subjects in a tertiary care hospital in Beijing, China
- (2019) Lifeng Liu et al. AIDS
- Dolutegravir-Based or Low-Dose Efavirenz–Based Regimen for the Treatment of HIV-1
- (2019) NEW ENGLAND JOURNAL OF MEDICINE
- Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance
- (2019) Philip L Tzou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevalence of integrase inhibitor resistance mutations in Austrian patients recently diagnosed with HIV from 2008 to 2013
- (2016) A. Zoufaly et al. INFECTION
- Prevalence of Integrase Strand Transfer Inhibitors (INSTI) Resistance Mutations in Taiwan
- (2016) Sui-Yuan Chang et al. Scientific Reports
- Primary resistance to integrase strand-transfer inhibitors in Europe: Table 1.
- (2015) M. Casadellà et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
- (2013) Pedro Cahn et al. LANCET
- Antiretroviral therapy: dolutegravir sets SAIL(ING)
- (2013) Mark A Boyd et al. LANCET
- Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011
- (2013) Fatemeh Jahanbakhsh et al. PLoS One
- Development of Elvitegravir Resistance and Linkage of Integrase Inhibitor Mutations with Protease and Reverse Transcriptase Resistance Mutations
- (2012) Mark A. Winters et al. PLoS One
- In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4
- (2011) Nicolas A. Margot et al. ANTIVIRAL RESEARCH
- HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
- (2011) Jose-Luis Blanco et al. JOURNAL OF INFECTIOUS DISEASES
- Elvitegravir: a once daily alternative to raltegravir
- (2011) Belete Ayele Desimmie et al. LANCET INFECTIOUS DISEASES
- MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods
- (2011) K. Tamura et al. MOLECULAR BIOLOGY AND EVOLUTION
- The evolution of HIV: Inferences using phylogenetics
- (2011) Eduardo Castro-Nallar et al. MOLECULAR PHYLOGENETICS AND EVOLUTION
- Appreciating HIV Type 1 Diversity: Subtype Differences in Env
- (2009) Rebecca M. Lynch et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Natural Polymorphisms of Human Immunodeficiency Virus Type 1 Integrase and Inherent Susceptibilities to a Panel of Integrase Inhibitors
- (2009) A. Low et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Raltegravir: a new choice in HIV and new chances for research
- (2009) Sean Emery et al. LANCET
- Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection
- (2008) Vincenzo Summa et al. JOURNAL OF MEDICINAL CHEMISTRY
- Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection
- (2008) David A. Cooper et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors
- (2008) Soo-Yon Rhee et al. Retrovirology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started